Active Pharmaceutical Ingredient (API)
Palbociclib
CDK4/6 Inhibitor
Inhibits cyclin-dependent kinases 4 and 6, blocking cell cycle progression from G1 to S phase. Used for HR+/HER2- breast cancer.
Technical Profile
- Reference Code
- ONC1004
- CAS Number
- 571190-30-2
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Palbociclib as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Palbocad 125 G | Beta Drugs Ltd | Capsule (125 mg) | ₹4,200.00 | View Details |